Active Ingredient: LUCINACTANT
Proprietary Name: SURFAXIN
Dosage Form; Route of Administration: SUSPENSION; INTRATRACHEAL
Strength: 8.5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021746
Product Number: 001
Approval Date: Mar 6, 2012
Applicant Holder Full Name: LEES PHARMACEUTICAL HK LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information